Published: Thu, February 15, 2018
Health | By Jay Jacobs

First Documented Case of Transgender Mother to Breastfeed

First Documented Case of Transgender Mother to Breastfeed

Her partner was pregnant with the baby, but didn't plan on breastfeeding, The Post reported.

The 30-year-old, who had been taking feminising hormones for six years but had not undergone any gender-related surgeries, sought the help of the Center for Transgender Medicine and Surgery.

While the results are promising for not only to the trans community but also to many other mothers who struggle with lactation. Wanting to ramp things up a little more, Reisman and Goldstein increased both her hormones and her domperidone intake.

She chose to breastfeed the 6 lbs 13 oz tot after her female partner - who carried the child - opted against it. Madeline Deutcsh from the University of California said that it is still unknown if the induced breastmilk from the transgender mother carries the positive long-term impact on the baby. A case study by a medical team from Mount Sinai in New York City, US, reports on the details of an experimental therapy.

Reisman and Goldstein say their January 1, 2018, report on the treatment is the first of its kind in medical literature.

Deutsch, director of clinical services at the UCSF Center of Excellence for Transgender Health, said she also is a transgender woman with a 6-month-old child.

"There have been self-reported cases online of transgender woman trying DIY regiments to induce breastfeeding, but this is the first case of induced functional lactation in the academic literature", Reisman told the news agency.

Over the course of three and a half months, the patient's dosage of domperidone, micronised progesterone and estradiol was increased and decreased accordingly in addition to her use of the breast pump.

The findings were published in the journal Transgender Health. "For all we know, breast stimulation alone might be sufficient".

But there are fears drugs taken to induce lactation in a person born a man may be harmful to the child.

Experiments on rats show it may be a cancer risk.

Doctor Deutsch is reluctant on this matter because there is no available information as to whether the medication used was transferred to the baby.

Reisman and Goldstein developed a regimen which included 10 milligrams of domperidone three times a day.

While Reisman and Goldstein's patient took her dose orally, the FDA is reportedly still anxious about the possible effects of domperidone on infants, since the drug is passed through breast milk.

She was given a breast pump which she used up to six times a day to get the milk flowing. After a month of treatment, the patient was reportedly producing "droplets" of milk.

Like this: